Literature DB >> 28575220

Vancomycin Taper and Risk of Failure of Fecal Microbiota Transplantation in Patients With Recurrent Clostridium difficile Infection.

Roberto L Patron1, Carlos A Hartmann1, Sorcha Allen2, Cheryl L Griesbach1, Heidi E Kosiorek3, John K DiBaise4, Robert Orenstein1.   

Abstract

We retrospectively analyzed a cohort of 109 subjects treated for recurrent Clostridium difficile infection with fecal microbiota transplantation (FMT) at a tertiary referral center between 2011 and 2014 to determine risk factors for FMT failure. In a multivariate analysis, failure to use an oral vancomycin taper preceding FMT was associated with a significant risk of FMT failure (odds ratio, 0.15; 95% confidence interval, .007-.40).

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28575220     DOI： 10.1093/cid/cix511

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  6 in total

1.  Clearance of Clostridioides difficile Colonization Is Associated with Antibiotic-Specific Bacterial Changes.

Authors:  Nicholas A Lesniak; Alyxandria M Schubert; Hamide Sinani; Patrick D Schloss
Journal:  mSphere       Date:  2021-05-05       Impact factor: 4.389

Review 2.  The Efficacy and Safety of Fecal Microbiota Transplant for Recurrent Clostridium difficile Infection: Current Understanding and Gap Analysis.

Authors:  Mark H Wilcox; Barbara H McGovern; Gail A Hecht
Journal:  Open Forum Infect Dis       Date:  2020-04-11       Impact factor: 3.835

3.  Faecal microbiota transplantation for recurrent Clostridioides difficile infection: An updated systematic review and meta-analysis.

Authors:  Simon Mark Dahl Baunwall; Mads Ming Lee; Marcel Kjærsgaard Eriksen; Benjamin H Mullish; Julian R Marchesi; Jens Frederik Dahlerup; Christian Lodberg Hvas
Journal:  EClinicalMedicine       Date:  2020-11-23

Review 4.  Inborn errors of immunity and related microbiome.

Authors:  Raja Hazime; Fatima-Ezzohra Eddehbi; Saad El Mojadili; Nadia Lakhouaja; Ikram Souli; Abdelmouïne Salami; Bouchra M'Raouni; Imane Brahim; Mohamed Oujidi; Morad Guennouni; Ahmed Aziz Bousfiha; Brahim Admou
Journal:  Front Immunol       Date:  2022-09-13       Impact factor: 8.786

Review 5.  Heterogeneity of Randomized Controlled Trials of Fecal Microbiota Transplantation in Recurrent Clostridioides difficile Infection.

Authors:  Paul Feuerstadt; Olga C Aroniadis; Felicia L Svedlund; Mariana Garcia; Laura Stong; Mena Boules; Sahil Khanna
Journal:  Dig Dis Sci       Date:  2021-07-18       Impact factor: 3.487

6.  Comorbid status and the faecal microbial transplantation failure in treatment of recurrent Clostridioides difficile infection - pilot prospective observational cohort study.

Authors:  M Kachlíková; P Sabaka; A Koščálová; M Bendžala; Z Dovalová; I Stankovič
Journal:  BMC Infect Dis       Date:  2020-01-16       Impact factor: 3.090
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.